A 5-month patient with ITP secondary to SARS-CoV-2
Pediatric Academic Case Reports · 2022
DOI: 10.61107/pacr.2022.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Academic Case Reports, 2022. Verfasst von Ibrahim Cemal Maslak. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Idiopathic thrombocytopenic purpura (ITP) is a hematological disease characterized by the immune-mediated destruction of platelets. It either resolves or becomes chronic. Before the onset of ITP, many children have an antecedent viral illness, which can be an upper respiratory infection or gastroenteritis. Regarding ITP frequency, infancy is the least prevalent age group when compared to older children. In this case report, we present the first infantile case of ITP associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was successfully treated with intravenous immunoglobulin (IVIg).
Zitieren
APA
Maslak, I. C. (2022). A 5-month patient with ITP secondary to SARS-CoV-2. Pediatric Academic Case Reports. https://doi.org/10.61107/pacr.2022.010
Vancouver
Maslak IC. A 5-month patient with ITP secondary to SARS-CoV-2. Pediatric Academic Case Reports. 2022. doi:10.61107/pacr.2022.010
BibTeX
@article{Maslak2022,
author = {Maslak, Ibrahim Cemal},
title = {A 5-month patient with ITP secondary to SARS-CoV-2},
journal = {Pediatric Academic Case Reports},
year = {2022},
doi = {10.61107/pacr.2022.010}
}
EUVIMED